 Connection
Charles Daley to Linezolid
This is a "connection" page, showing publications Charles Daley has written about Linezolid.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.485 |
|
|
|
-
Kim SY, Jhun BW, Moon SM, Jeon K, Kwon OJ, Huh HJ, Lee NY, Shin SJ, Daley CL, Koh WJ. Genetic mutations in linezolid-resistant Mycobacterium avium complex and Mycobacterium abscessus clinical isolates. Diagn Microbiol Infect Dis. 2019 May; 94(1):38-40.
Score: 0.144
-
Winthrop KL, Ku JH, Marras TK, Griffith DE, Daley CL, Olivier KN, Aksamit TR, Varley CD, Mackey K, Prevots DR. The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease. Eur Respir J. 2015 Apr; 45(4):1177-9.
Score: 0.110
-
Chang KC, Leung CC, Daley CL. Linezolid for multidrug-resistant tuberculosis. Lancet Infect Dis. 2012 Jul; 12(7):502-3.
Score: 0.092
-
Daley CL. Update in tuberculosis 2009. Am J Respir Crit Care Med. 2010 Mar 15; 181(6):550-5.
Score: 0.079
-
Poonawala H, Davis K, Kenny ME, Alivisatos A, Van N, Washington T, Calado Nogueira de Moura V, Daley CL, Aldridge BB. Antibiotic dose-response curves can measure antibiotic activity against Mycobacterium abscessus and Mycobacterium peregrinum. Antimicrob Agents Chemother. 2026 05 06; 70(5):e0187625.
Score: 0.060
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|